Crossmark

Efficacy and safety of programmable compared with fixed anti-siphon devices for treating idiopathic normal-pressure hydrocephalus (iNPH) in adults – SYGRAVA: study protocol for a randomized trial

Crossref DOI link: https://doi.org/10.1186/s13063-018-2951-6

Published Online: 2018-10-17

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Scholz, Romy

Lemcke, Johannes http://orcid.org/0000-0002-8073-1625
Meier, Ullrich

Stengel, Dirk
Funding

Funding for this research was provided by:

Aesculap AG
License Information

Text and Data Mining valid from 2018-10-17
More Information

Article History

Received: 10 October 2017

Accepted: 28 September 2018

First Online: 17 October 2018

Ethics approval and consent to participate

: The conduct of this study will comply with the International Conference for Harmonization Good Clinical Practice (ICH-GCP) regulations and guidelines and the current revision of the Declaration of Helsinki. Approval was obtained from the Charité Ethics Board on 2 September 2016 (EA1/234/16). Informed consent will be obtained from all participants before inclusion in the study. Participants may withdraw consent at any time.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below